An expedient entry to fused [1,2,5]-triazepine derivatives: Extension to fused [1,2,5]-oxadiazine derivatives, a new class of seven-membered heterocycles

Synlett

Volumn , Issue 9, 2009, Pages 1463-1465

  Reddy, Gade Srinivas ^a   Kumar, Prataprao Anil ^a   Anand, Ramasamy Vijaya ^a   Mukkanti, Kaga ^b   Reddy, Padi Pratap ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

1,2,5 oxadiazines; 1,2,5 triazepines; Fused ring systems; Heterocycles; Indoles

Indexed keywords

[1,2,5] OXADIAZINE DERIVATIVE; [1,2,5] TRIAZEPINE DERIVATIVE; INDOLE DERIVATIVE; OXADIAZOLE DERIVATIVE; TRIAZENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPERATURE MEASUREMENT;

EID: 67649397433     PISSN: 09365214     EISSN: 14372096     Source Type: Journal    
DOI: 10.1055/s-0029-1217178     Document Type: Article

References (34)

1. IPD communication number: DRL-IPDO-IPM-00176.
2. (a) Eicher, T.; Hauptmann, S. The Chemistry of Heterocycles, 2nd ed.; Wiley-VCH: Weinheim, 2003, 461-479.
3. (b) Bellantuono, C.; Reggi, G.; Tognoni, G.; Garattini, S. Drugs 1980, 19, 195.
4. (a) Sternbach, L. H. J. Med. Chem. 1979, 22, 1.
5. (b) Williams, M. J. Med. Chem. 1983, 26, 619.
6. (c) Snieckus, V.; Streith, J. Acc. Chem. Res. 1981, 14, 348.
7. (d) Itto, M. Y. A.; Hasnaoui, A.; Riahi, A.; Lavergne, J.-P. Tetrahedron Lett. 1997, 38, 2087.
8. (e) Quan, H.-J.; Koyanagi, J.; Hagiwara, K.; Cui, X.-R.; Isshiki, Y.; Kondo, S.; Komada, F.; Saito, S. Chem. Pharm. Bull. 2006, 54, 73.
9. Sui, Z.; Walsh, S. P. US Patent, 6821993B1, 2004.
10. Lenman, M. M.; Lewis, A.; Gani, D. J. Chem. Soc., Perkin Trans. 1 1997, 2297.
11. (a) Seebacher, W.; Michl, G.; Weis, A. Tetrahedron Lett. 2002, 43, 7481.
12. (b) Rezessy, B.; Zubocics, Z.; Kovacs, J.; Toth, G. Tetrahedron 1999, 55, 5909.
13. (c) Adamo, M. F. A.; Baldwin, J. E.; Adlington, R. M. J. Org. Chem. 2005, 70, 3307; and references cited therein.
14. (a) Saveleva, E. A.; Rozin, Y. A.; Kodess, M. I.; Meervelt, L. V.; Dehaen, W.; Morzherin, Y. Y.; Bakulev, V. A. Tetrahedron 2004, 60, 5367.
15. (b) Zaleska, B.; Trzewik, B.; Grochowski, J.; Serda, P. Synthesis 2003, 2559.
16. (c) Katritzky, A. R.; Fan, W.-Q.; Greenhill, J. V. J. Org. Chem. 1991, 56, 1299.
17. (d) Lenman, M. M.; Lewis, A.; Gani, D. J. Chem. Soc., Perkin Trans. 1 1997, 2297.
18. (e) Bouteau, B.; Imbs, J.-L.; Lancelot, J.-C.; Barthelmebs, M.; Robba, M. Chem. Pharm. Bull. 1991, 39, 81.
19. (f) Kirchner, E.; Bretschneider, H. Monatsh. Chem. 1971, 102, 162.
20. Scott, A. I. Acc. Chem. Rev. 1970, 3, 151.
21. (a) Flynn, B. L.; Hamel, E.; Junk, M. K. J. Med. Chem. 2002, 45, 2670.
22. (b) Chao, W.-R.; Yean, D.; Amin, K.; Green, C.; Jong, L. J. Med. Chem. 2007, 50, 3412.
23. (c) Breslin, H. J.; Miskowski, T. A.; Kukla, M. J.; Leister, W. H.; Winter, H. L. D.; Gauthier, D. A.; Somers, M. V. F.; Peeters, D. C. G.; Roevens, P. W. M. J. Med. Chem. 2002, 45, 5303.
24. Pletnev, A. A.; Tian, Q.; Larock, R. C. J. Org. Chem. 2002, 67, 9276.
25. 2 [M + 1]: 291.1134; found: 291.1121.
26. 4O [M + 1]: 305.1402; found: 305.1403.
27. (a) Cho, S. Y.; Kang, S. K.; Ahn, J. H.; Ha, J. D.; Choi, J.-K. Tetrahedron Lett. 2006, 47, 9029.
28. (b) Srivastava, R. M.; de Morais, L. P. F.; de Melo Souto, S. C.; Carpenter, G. B.; de Carvalho, L. T. Tetrahedron Lett. 2006, 47, 3173.
29. (c) Tabei, K.; Kawashima, E.; Takada, T.; Kato, T. Chem. Pharm. Bull. 1982, 30, 3987.
30. Butler, R. N.; McMahon, J. M.; McDonald, P. D.; Pyne, C. S.; Schambony, S.; McArdle, P.; Cunningham, D. J. Chem. Soc., Perkin Trans. 1 1997, 1047.
31. Makula, D.; Druet, M.; Gonthier, B. US Patent, 3696099, 1972.
32. Hansen, D. W. Jr.; Hallinan, E. A.; Awasthi, A. K.; Metz, S.; Scholten, J. A.; Snyder, J. S.; Toth, M. V.; Webber, R. K. US Patent, 6774126B2, 2004.
33. Takacs, K.; Simay, A.; Kiss, I.; Nagy, P. L.; Hetvey, M.; Escery, M.; Szegy, J.; Viragh, S.; Nagy, S. J. US Patent, 4308270, 1981.
34. 2 [M + 1]: 306.1243; found: 305.1234.